1. Home
  2. ONEG vs PDSB Comparison

ONEG vs PDSB Comparison

Compare ONEG & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneConstruction Group Limited Ordinary Shares

ONEG

OneConstruction Group Limited Ordinary Shares

HOLD

Current Price

$3.59

Market Cap

33.3M

ML Signal

HOLD

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$1.08

Market Cap

29.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONEG
PDSB
Founded
2021
2005
Country
Hong Kong
United States
Employees
26
10
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.3M
29.6M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
ONEG
PDSB
Price
$3.59
$1.08
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.00
AVG Volume (30 Days)
574.0K
841.4K
Earning Date
01-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.16
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.96
$0.51
52 Week High
$13.50
$1.90

Technical Indicators

Market Signals
Indicator
ONEG
PDSB
Relative Strength Index (RSI) 74.14 74.98
Support Level $1.16 $1.02
Resistance Level $5.70 $1.12
Average True Range (ATR) 0.43 0.11
MACD 0.21 0.06
Stochastic Oscillator 92.31 90.37

Price Performance

Historical Comparison
ONEG
PDSB

About ONEG OneConstruction Group Limited Ordinary Shares

OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. The company is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction project includes performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Share on Social Networks: